Aqr Capital Management LLC Zai Lab LTD Transaction History

Aqr Capital Management LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$27.77 - $64.4 $3.44 Million - $7.98 Million	-123,917 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$54.9 - $105.21 $104,804 - $200,845	-1,909 Reduced 1.52%	123,917 $7.79 Million
Q3 2021 Nov 15, 2021	SELL	$105.0 - $178.37 $31,290 - $53,154	-298 Reduced 0.24%	125,826 $13.3 Million
Q2 2021 Aug 16, 2021	BUY	$125.11 - $180.0 $33,404 - $48,060	267 Added 0.21%	126,124 $22.3 Million
Q1 2021 May 17, 2021	BUY	$126.27 - $191.71 $1.99 Million - $3.02 Million	15,772 Added 14.33%	125,857 $16.8 Million
Q4 2020 Feb 16, 2021	BUY	$81.94 - $135.34 $8.62 Million - $14.2 Million	105,253 Added 2178.25%	110,085 $14.9 Million
Q3 2020 Nov 16, 2020	BUY	$73.3 - $89.48 $149,238 - $182,181	2,036 Added 72.82%	4,832 $402,000
Q2 2020 Aug 17, 2020	BUY	$48.82 - $82.53 $136,500 - $230,753	2,796 New	2,796 $230,000
Q1 2020 May 15, 2020	SELL	$39.1 - $62.9 $1.55 Million - $2.49 Million	-39,548 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$25.73 - $35.79 $1.02 Million - $1.42 Million	39,548 New	39,548 $1.38 Million
Q1 2019 May 14, 2019	SELL	$21.71 - $31.54 $190,613 - $276,921	-8,780 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$14.95 - $24.72 $131,261 - $217,041	8,780 New	8,780 $204,000

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.95B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.